You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普利製藥(300630.SZ):取得發明專利證書一份
格隆匯 12-25 20:13

格隆匯12月25日丨普利製藥(300630.SZ)公佈,公司近日取得了中華人民共和國國家知識產權局頒發的發明專利證書一份,發明名稱為海蔘多糖腸溶微丸及其製備方法。

海蔘多糖腸溶微丸包括將海蔘多糖混合製劑輔料加載到丸芯上形成微丸素丸,用隔離層包衣液包裹形成的隔離層和用腸溶層包衣液包裹形成的腸溶包衣層;本發明海蔘多糖腸溶微丸,在胃內不溶出在腸道內快速溶解吸收,避免了海參多糖在胃內被胃酸所降解,影響其生物利用度。

上述發明專利證書的取得不會對公司生產經營產生重大影響,但有利於充分發揮公司自主知識產權優勢,對公司開拓市場及推廣產品產生積極的影響,形成創新機制,保持公司技術的領先性,提升公司的核心競爭能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account